Clinical Trial Update: What is the Predictive Value of the Reflux Impact Scale

View source ↗

Summary

AstraZeneca reports a terminated clinical trial evaluating the predictive value of the Reflux Impact Scale for GERD-related symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease, GERD | Status: TERMINATED